Clinical studies

Research for our patients

If you have any questions regarding the studies, please get in touch with the respective contact persons at theStudy Secretariats Internal Medicine I

 

Gastrointestinal oncology: Clinical study centre
Profilbild von Dr. med. Thomas J. Ettrich

Dr. med. Thomas J. Ettrich

Oberarzt, Leiter Schwerpunkt GI-Onkologie, Leiter des klinischen Studienzentrums GI-Onkologie

Chronic inflammatory bowel disease:
Profilbild von PD Dr. med. Jochen Klaus, MBA

PD Dr. med. Jochen Klaus, MBA

Oberarzt, Leiter Schwerpunkt CED, QMB, Facharzt für Innere Medizin, Gastroenterologie, Geriatrie, Palliativmedizin

Liver and biliary tract diseases:
Profilbild von PD Dr. med. Eugen Zizer

PD Dr. med. Eugen Zizer

Oberarzt, Leiter Hepatologie

Interventional and experimental endoscopy

Profilbild von Prof. Dr. med. Benjamin M. Walter

Prof. Dr. med. Benjamin M. Walter

Oberarzt, Leiter Endoskopie

Microbiome

Profilbild von Prof. Dr. med. Martin Wagner

Prof. Dr. med. Martin Wagner

Stellvertretender Ärztlicher Direktor, Klinik für Innere Medizin I

Kidney diseases, kidney transplantation

Profilbild von Prof. Dr. med. Bernd Schröppel

Prof. Dr. med. Bernd Schröppel

Leiter der Sektion Nephrologie

Pancreatic diseases, IgG4-associated diseases

Profilbild von Prof. Dr. rer. med. Alexander Kleger

Prof. Dr. rer. med. Alexander Kleger

Leiter Sektion Interdisziplinäre Pankreatologie, Direktor Institut für Molekulare Onkologie und Stammzellbiologie, Heisenberg Professor für Molekulare Onkologie, Leiter Core Facility Organoids

Sonographic diagnostic procedures

Profilbild von Prof. Dr. med. Wolfgang Kratzer

Prof. Dr. med. Wolfgang Kratzer

Oberarzt, Leiter Zentraler Ultraschall

Clinical research and basic research at the Department of Internal Medicine I

The basis for medical progress

Competence area prevention and early detection of tumour diseases

Management

The "Competence Area Prevention and Early Detection of Tumour Diseases" is one of the five competence areas of the Baden-Württemberg Preventive Medicine Competence Network.

With the PREVENT-TAKE-UP app, we contribute to the promotion of public health as part of this competence network. In particular, we promote health awareness, personal responsibility and individual health literacy.

 

Initial situation
  • Prevention and early detection measures are of paramount importance in oncology.
  • Prevention measures are not yet being taken up by the population to the extent required.
  • Lack of low-threshold services for individualised prevention recommendations that take into account particular risk factors, e.g. family history, and also make prevention recommendations for younger people.
  • Digital tools such as smartphones are now widespread and attractive instruments for providing users with up-to-date information in a well-organised form via an app.

 

Objectives
  • Improve the acceptance of prevention and early detection measures.
  • To comprehensively sensitise people who are entitled to preventive measures but have not yet taken advantage of preventive measures to cancer screening and early detection in line with guidelines and to contribute to informed decision-making by these people.
  • More frequent detection of tumours at an earlier stage through early detection with a high chance of cure.
  • The PREVENT-TAKE-UP app takes information on prevention and early detection for the three most common tumour entities - colorectal cancer, breast cancer and prostate cancer - to a new dimension and supports informed decision-making among users through optimised, individualised information tailored to the needs and requirements of the target group.

Multidisciplinary development of the app at the Ulm site
  • Development of the app by the Institute of Medical Systems Biology at the University of Ulm in close cooperation with the Gastroenterology, Gynaecology, Urology and the Institute of General Medicine.
  • Focus on correct and guideline-compliant information, user-friendliness of the app and comprehensibility of patient-oriented content through suitable methods of visualisation.
  • General and tumour-specific questions of the app are developed by the respective experts and reflected in focus groups for a quality-assured information content.
  • Application and feasibility study: Testing of the app with the involvement of primary care providers and a generic group of people for the improvement, further development and finalisation of the app.
  • The revised final version of the app will be uploaded to the respective app stores for free download.
  • The app is designed in such a way that it can be modularly extended to other tumour entities (e.g. skin cancer) and continuously updated in line with the latest scientific findings.